CSIMarket Company Name, Ticker, Suppliers, else..


Fate Therapeutics Inc   (NASDAQ: FATE)
Other Ticker:  
 

Fate Therapeutics Inc

FATE's Fundamental analysis



Looking into Fate Therapeutics Inc growth rates, revenue grew by 58.13 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 2477

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 13.29 %

Fate Therapeutics Inc net loss increased from $-45 millions, to $-48 millions in III. Quarter 2024,

• More on FATE's Growth


Fate Therapeutics Inc
realized a net loss in trailing twelve months.

Fate Therapeutics Inc realized cash reduction of $ -0 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 10.99.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.06.


• More on FATE's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 61,123
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 6.84
 Tangible Book Value (Per Share $) 3.08

Fate Therapeutics Inc
realized net loss in trailing twelve months.

Fate Therapeutics Inc realized cash outflow of $ -0per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 10.99.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.06.

Fate Therapeutics Inc Price to Book Ratio is at 0.41 higher than Industry Avg. of -0, and higher than S&P 500 Avg. of 0.01

• More on FATE's Valuation

•  Market Capitalization (Millions $) 148
•  Shares Outstanding (Millions) 118
•  Employees 220
•  Revenues (TTM) (Millions $) 13
•  Net Income (TTM) (Millions $) -178
•  Cash Flow (TTM) (Millions $) 0
•  Capital Exp. (TTM) (Millions $) -1
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 61,123
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 6.84
•  Tangible Book Value (Per Share $) 3.08

•  Market Capitalization (Millions $) 148
•  Shares Outstanding (Millions) 118
•  Employees 220
•  Revenues (TTM) (Millions $) 13
•  Net Income (TTM) (Millions $) -178
•  Cash Flow (TTM) (Millions $) 0
•  Capital Exp. (TTM) (Millions $) -1





  Ratio
•   Capital Ratio (MRQ) 8.29
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.1
•  Asset Turnover Ratio (TTM) 0.03
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com